| 1. |
Chacko G, Thomas G, Babu S, et al. Awake craniotomy and electrophysiological mapping for eloquent area tumours. Clin Neurol Neurosurg, 2013, 115(3): 329-334.
|
| 2. |
Burchiel KJ, Clarke H, Ojemann GA, et al. Use of stimulation mapping and corticography in the excision of arteriovenous malformations in sensorimotor and language-related neocortex. Neurosurgery, 1989, 24(3): 322-327.
|
| 3. |
Trimble G, Mcstravick C, Farling P, et al. Awake craniotomy for glioma resection: technical aspects and initial results in a single institution. Br J Neurosurg, 2015, 29(6): 836-842.
|
| 4. |
Pouratian N, Cannestra AF, Bookheimer SY, et al. Variability of intraoperative electrocortical stimulation mapping parameters across and within individuals. J Neurosurg, 2004, 101(3): 458-466.
|
| 5. |
Mclean J, Diaz-Gil Daniel, Farhan N, et al. Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology, 2015, 122(6): 1201-1213.
|
| 6. |
Olsen KS. The asleep-awake technique using propofol-remifentanil anaesthesia for awake craniotomy for cerebral tumours. Eur J Anaesthesiol, 2008, 25(8): 662-669.
|
| 7. |
Moore TA, Markert JM, Knowlton RC. Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection. Anesth Analg, 2006, 102(5): 1556-1558.
|
| 8. |
Fourcade O, Simon MF, Litt L, et al. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesth Analg, 2004, 99(2): 393-398, table of contents.
|
| 9. |
Mcclellan J, Faulds D. Ropivacaine: an update of its use in regional anaesthesia. Drugs, 2000, 60(5): 1065-1093.
|
| 10. |
Hansen MS, Brennum J, Moltke FB, et al. Pain treatment after craniotomy: where is the (procedure-specific) evidence? A qualitative systematic review. Eur J Anaesthesiol, 2011, 28(12): 821-829.
|
1/5
WeChat